Sure, maybe management did make some questionable decisions, and perhaps the PI was especially tough to work for. But a resignation letter is probably not the best place to bring that up, Suzanne Lucas notes at her Evil HR Lady blog.
Registering provides access to this and other free content.
Already have an account?Login Now.
The New York Times' George Johnson muses on cancer's roots in multicellularity.
The San Diego Union Tribune wonders whether Medicare is ready for personalized medicine.
Jun Wang, the chief executive of BGI, has stepped down.
In PNAS this week: human T cell editing with CRISPR, retrotransposons acting as insulators, and more.